The Leeds-based business reported revenue of £4.22m for the six months ended 30 June, 2021, up from £2.59m during the same period last year and 83 per cent of the comparable pre-pandemic period in 2019 when it stood at £5.10m.
Nigel Rogers, chairman of Surgical Innovations, said: "A strong recovery in trading is evident from the results for the first half of the year, and this view is further reinforced by the continued improvement in revenues in post-period trading.
"The steps taken by management last year, initially to protect the business and subsequently to simplify and strengthen our operational and regulatory processes, are having demonstrably positive effects on the financial and commercial effectiveness of the business.
"With a strengthened management team, and further improved distribution network and product range, we firmly believe that the group is well placed to continue its recovery to pre-pandemic levels in most major markets in the coming months.
"Our differentiated 'Resposable' product offering is gaining traction and the board sees encouraging prospects for 2022 and beyond."
Support The Yorkshire Post and become a subscriber today.
Your subscription will help us to continue to bring quality news to the people of Yorkshire. In return, you'll see fewer ads on site, get free access to our app and receive exclusive members-only offers.
So, please - if you can - pay for our work. Just £5 per month is the starting point. If you think that which we are trying to achieve is worth more, you can pay us what you think we are worth. By doing so, you will be investing in something that is becoming increasingly rare. Independent journalism that cares less about right and left and more about right and wrong. Journalism you can trust.